Intracranial dural arteriovenous fistula with retrograde cortical venous drainage: use of susceptibility-weighted imaging in combination with dynamic susceptibility contrast imaging.
OBJECTIVE
SWI is a new MR imaging method that maximizes sensitivity to magnetic susceptibility effects with phase information for visualizing small cerebral veins. The purpose of this study was to report the use of SWI in combination with DSC in examining related RCVD in patients with intracranial DAVFs.


METHODS
Ten patients with angiographically confirmed DAVFs with RCVD underwent conventional MR imaging, SWI, and DSC. The ability of SWI to depict dilated cerebral veins was evaluated and then compared with DSC. The hemispheres of patients with DAVFs were grouped into affected (with RCVD) or nonaffected (without RCVD) categories by angiography. Four patients had bilaterally affected hemispheres. A total of 14 affected hemispheres in patients with DAVFs with RCVD were evaluated.


RESULTS
SWI showed dilated cerebral veins on the surface of the brain in all (100%) of the 14 affected hemispheres in patients with DAVFs with RCVD and deep in the brain in 9 (64%). T2-weighted imaging showed prominent flow-voids on the surface of the brain in 10 (71%) of the 14 affected hemispheres in patients with DAVFs with RCVD and deep in the brain in 5 (36%). DSC showed increased cerebral blood volume in all of the 14 affected hemispheres. The SWI findings regarding dilated veins on the surface of the brain corresponded well with the areas of increased cerebral blood volume.


CONCLUSIONS
SWI in combination with DSC could be used to characterize the presence of RCVD in patients with DAVFs.
Noguchi
K
K
Department of Radiology, Toyama University, Japan. kyo@med.u-toyama.ac.jp
Kuwayama
N
N
Kubo
M
M
Kamisaki
Y
Y
Kameda
K
K
Tomizawa
G
G
Kawabe
H
H
Seto
H
H
D000368:Aged; D001810:Blood Volume; D020785:Central Nervous System Vascular Malformations / Q000473:pathology*; D002533:Cerebral Angiography; D002540:Cerebral Cortex / Q000098:blood supply; D002543:Cerebral Hemorrhage / Q000473:pathology; D002550:Cerebral Veins / Q000473:pathology*; D003287:Contrast Media; D005260:Female; D006801:Humans; D018810:Magnetic Resonance Angiography; D008279:Magnetic Resonance Imaging / Q000295:instrumentation* / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity; D054063:Superior Sagittal Sinus / Q000473:pathology
D003287:Contrast Media
AJNR Am J Neuroradiol. 2006 Jun-Jul;27(6):1252-6
16775275
AJNR Am J Neuroradiol. 2009 Sep;30(8):1546-51
19474117
J Neurosurg. 1995 Feb;82(2):166-79
7815143
Stroke. 2002 May;33(5):1233-6
11988596
Biochim Biophys Acta. 1982 Feb 2;714(2):265-70
6275909
AJNR Am J Neuroradiol. 2002 Mar;23(3):404-7
11901008
Magn Reson Med. 2004 Sep;52(3):612-8
15334582
Radiology. 1992 Apr;183(1):265-71
1549684
J Neurosurg. 1986 Apr;64(4):554-8
3950738
Neurosurgery. 1984 Sep;15(3):332-9
6483147
AJNR Am J Neuroradiol. 2006 Feb;27(2):264-9
16484389
AJNR Am J Neuroradiol. 2009 Jan;30(1):E6
18818280
J Magn Reson Imaging. 2009 Mar;29(3):537-44
19243035
Radiology. 1990 Apr;175(1):193-9
2315480
AJNR Am J Neuroradiol. 1999 Jun-Jul;20(6):1031-6
10445439
Radiology. 2003 May;227(2):332-9
12732694
Ann Neurol. 2004 Jul;56(1):36-50
15236400
AJR Am J Roentgenol. 2004 Jan;182(1):183-90
14684537
Neuroradiology. 2007 Aug;49(8):639-43
17372729
AJNR Am J Neuroradiol. 1998 Aug;19(7):1267-73
9726465
Radiology. 1997 Jul;204(1):272-7
9205259
Invest Radiol. 2003 Jul;38(7):409-14
12821854
AJNR Am J Neuroradiol. 1999 Aug;20(7):1239-42
10472978
J Neurosurg. 1986 May;64(5):724-30
3701421
J Magn Reson Imaging. 1998 Nov-Dec;8(6):1236-9
9848734
J Neurosurg. 1990 Jun;72(6):839-50
2140125
Radiology. 1995 Mar;194(3):671-80
7862961
AJNR Am J Neuroradiol. 1994 Sep;15(8):1501-7
7985570
Neuroradiology. 2001 May;43(5):364-9
11396739
AJNR Am J Neuroradiol. 2010 Jan;31(1):80-5
19833802
J Magn Reson Imaging. 2004 Sep;20(3):372-7
15332242
Magn Reson Imaging. 1999 Oct;17(8):1141-8
10499676